SecurityCHKDG / Chesapeake Energy Corp., 5.00% Cumulative Convertible Preferred Stock (165167826)
IndustryCrude Petroleum and Natural Gas
Common Shares Outstanding912,274,017 shares (as of 2018-06-30)
Total Insiders21
Total Directors13
Total Officers9

Stock Insider Trading (from SEC Form 4)

Chesapeake Energy Corp., 5.00% Cumulative Convertible Preferred Stock insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

CHKDG / Chesapeake Energy Corp., 5.00% Cumulative Convertible Preferred Stock insiders include MARTIN R BRAD, POSES FREDERIC M, MILLER MERRILL A JR, Querrey Kimberly K., Boyland Gloria R., CORBETT LUKE R, DOYLE M. CHRISTOPHER, and JOHNSON MICHAEL A, Jacobson Douglas J INTRIERI VINCENT J, PIGOTT M. JASON, DELL'OSSO DOMENIC J JR, DUNHAM ARCHIE W, LIPINSKI JOHN J, WEBB JAMES R, KEATING LESLIE STARR, Patterson Frank J., Lawler Robert D., BUERGLER WILLIAM M, RYAN THOMAS L, RASPINO LOUIS, .

Insider Roster

Insider Dir Off 10% Shares Owned
KEATING LESLIE STARR Director
X 107,798
RYAN THOMAS L Director
X 538,060
Patterson Frank J. EVP-Exploration & Production
X 791,691
Lawler Robert D. CEO, Director
X X 4,054,419
MILLER MERRILL A JR Director
X 379,050
MARTIN R BRAD Director
X 692,900
DUNHAM ARCHIE W Director
X 4,847,375
CORBETT LUKE R Director
X 106,855
Boyland Gloria R. Director
X 107,941
WEBB JAMES R EVP-Gen'l Counsel & Corp. Sec.
X 821,548
PIGOTT M. JASON EVP - Operations
X 1,004,521
DELL'OSSO DOMENIC J JR Exec. Vice President & CFO
X 1,353,283
BUERGLER WILLIAM M SVP & Chief Accounting Officer
X 160,905
JOHNSON MICHAEL A SVP-Accounting Controller
X
Querrey Kimberly K. Director
X
LIPINSKI JOHN J Director
X
INTRIERI VINCENT J Director
X
POSES FREDERIC M Director
X
DOYLE M. CHRISTOPHER EVP - Operations
X
RASPINO LOUIS Director
X
Jacobson Douglas J EVP-Acquisitions/Divestitures
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-07-02 4 RYAN THOMAS L A D 5.18 4,826 538,060
2018-07-02 4 KEATING LESLIE STARR A D 5.18 4,826 107,798
2018-06-30 4 Patterson Frank J. F D 5.24 -26,194 791,691
2018-06-17 4 Lawler Robert D. A D 1,077,587 4,054,419
2018-06-17 4 Lawler Robert D. F D 4.64 -37,249 2,976,832
2018-05-18 4 Boyland Gloria R. A D 61,577 107,941
2018-05-18 4 CORBETT LUKE R A D 61,577 106,855
2018-05-18 4 DUNHAM ARCHIE W A D 123,153 4,847,375
2018-05-18 4 KEATING LESLIE STARR A D 61,577 102,972
2018-05-18 4 MARTIN R BRAD A D 130,542 692,900
2018-05-18 4 MILLER MERRILL A JR A D 65,271 379,050
2018-05-18 4 RYAN THOMAS L A D 67,734 533,234
2018-04-02 4 KEATING LESLIE STARR A D 2.97 8,418 41,395
2018-04-02 4 RYAN THOMAS L A D 2.97 8,418 465,500
2018-03-19 4 Lawler Robert D. A D 1,000,000 3,014,081
2018-03-19 4 BUERGLER WILLIAM M A D 83,057 160,905
2018-03-19 4 DELL'OSSO DOMENIC J JR A D 365,449 1,353,283
2018-03-19 4 Patterson Frank J. A D 365,449 817,885
2018-03-19 4 PIGOTT M. JASON A D 332,226 1,004,521
2018-03-19 4 WEBB JAMES R A D 332,226 821,548
2018-03-15 4 BUERGLER WILLIAM M F D 3.02 -2,506 77,848
2018-03-15 4 DELL'OSSO DOMENIC J JR F D 3.02 -27,126 987,834
2018-03-15 4 Lawler Robert D. F D 3.02 -97,200 2,014,081
2018-03-15 4 Patterson Frank J. F D 3.02 -27,126 452,436
2018-03-15 4 PIGOTT M. JASON F D 3.02 -22,605 672,295
2018-03-15 4 WEBB JAMES R F D 3.02 -22,605 489,322
2018-01-14 4 DELL'OSSO DOMENIC J JR F D 4.28 -29,487 1,014,960
2018-01-14 4 Lawler Robert D. F D 4.28 -123,699 2,111,281
2018-01-14 4 Patterson Frank J. F D 4.28 -25,343 479,562
2018-01-14 4 PIGOTT M. JASON F D 4.28 -24,793 694,900
2018-01-14 4 WEBB JAMES R F D 4.28 -24,801 511,927
2018-01-10 4 DELL'OSSO DOMENIC J JR F D 4 -5,124 1,044,447
2018-01-10 4 Lawler Robert D. F D 4 -16,654 2,234,980
2018-01-10 4 PIGOTT M. JASON F D 4 -4,270 719,693
2018-01-10 4 WEBB JAMES R F D 4 -4,270 536,728
2018-01-02 4 KEATING LESLIE STARR A D 4.10 6,097 32,977
2018-01-02 4 RYAN THOMAS L A D 4.10 6,097 457,082
2017-12-29 4 BUERGLER WILLIAM M A D 3.96 21,840 80,354
2017-12-29 4 DELL'OSSO DOMENIC J JR A D 3.96 73,048 1,049,571
2017-12-29 4 Lawler Robert D. A D 3.96 147,331 2,251,634
2017-12-29 4 PIGOTT M. JASON A D 3.96 57,935 723,963
2017-12-29 4 WEBB JAMES R A D 3.96 62,973 540,998
2017-12-13 4 RYAN THOMAS L by Trust G I 180,000 180,000
2017-12-13 4 RYAN THOMAS L G D -180,000 270,985
2017-10-02 4 RYAN THOMAS L A D 4.35 5,747 450,985
2017-10-02 4 KEATING LESLIE STARR A D 4.35 5,747 26,880
2017-09-30 4 BUERGLER WILLIAM M F D 4.30 -1,440 58,514
2017-09-11 4 KEATING LESLIE STARR A D 21,133 21,133
2017-08-14 4 PIGOTT M. JASON F D 4.07 -20,781 666,028
2017-08-11 4 MARTIN R BRAD P D 4.105 25,000 562,358 2,308,480
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Oil Prices Fall Despite Supply Fears

16h oilprice
Tom majored in International Business at Amsterdam’s Higher School of Economics, he is now working as news editor for Oilprice.com. (86-0)

Smart Sand Changes Northern White Narrative

22h seekingalpha
Smart Sand is shipping record volumes and posting record income, yet its stock price has severely underperformed peers and the overall market. (29-0)

Fracking Equation Has Changed: Hi Crush Is The Way To Play It

2018-08-13 seekingalpha
Breakevens have been cut in half since the crash in 2014, allowing E&Ps to still frack at a profit, now even during a downturn. (29-1)

Gold Company Makes Huge Blunder By Investing In U.S. Shale Assets

2018-08-13 seekingalpha
Something took place in the gold industry that I thought would never happen. In a stunning press release, Franco-Nevada (NYSE:FNV) announced that it was taking a financial stake in U.S. shale energy assets. Why on earth is one of the top gold royalty companies investing in an industry in which it has no expertise… especially in the shale oil industry?? (29-0)

Chesapeake Energy: Probably One More Multi-Billion Sale Needed

2018-08-12 seekingalpha
However, the working capital deficit ballooned to $1.6 billion. Many include that deficit in the long term debt calculations. (29-0)